CompletedNCT05783687

Real World Evidence Study in Subjects With Wilson's Disease

Studying Wilson disease

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Orphalan
Principal Investigator: Mike Schilsky, MD
Yale University School of Medicine, New Haven, Connecticut
Intervention: NCC-Sp Assay(diagnostic_test)
Enrollment: 50 enrolled
Eligibility: 18 years · All sexes
Timeline: 2023 – 2025

Study locations (9)

UC Davis Midtown Ambulatory Care Centre, Sacramento, California, United States
Yale University School of Medicine, New Haven, Connecticut, United States
University of Miami, Miami, Florida, United States
Advent Health Orlando, Orlando, Florida, United States
Northwestern University Chicago (Hepatologist), Chicago, Illinois, United States
John Hopkins Hospital, Baltimore, Maryland, United States
University of Michigan, Ann Arbor, Michigan, United States
New York Presbyterian Hospital-Columbia University Medical Centre, New York, New York, United States
Vanderbilt University Medical Centre, Nashville, Tennessee, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05783687 on ClinicalTrials.gov

Other trials for Wilson disease

Additional recruiting or active studies for the same condition.

See all trials for Wilson disease →

← Back to all trials